• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Rheumatology

Show Search
Hide Search
  • About Us
    • Our History
    • Our Faculty
    • Rheumatology Fellowship
    • Administrative Core
    • Contact Us
    • eNews Signup
  • Make an Appointment
    • Clinic Information
    • Specialty Clinics
  • Our Research
    • Current Research Studies
    • Andrade Lab
    • Darrah Lab
    • Konig Lab
    • Rosen Casciola Lab
    • RDRCC
    • Bayview Immunomics Core (BIC)
  • Charitable Giving
    • Dr. John Welton Fellowship in Rheumatology
    • Dr. Ira T. Fine Discovery Fund
    • Dr. Nadia D. Morgan Memorial Fund
  • News
    • LEAP Magazine
  • Education
    • Advances in the Diagnosis and Treatment of the Rheumatic Diseases Course
    • RheumTV – Patient Education Video Library
Home / Research Studies / Clinical Trial: Efficacy, Safety, and Tolerability of PF-06823859 in Patients With Dermatomyositis

Clinical Trial: Efficacy, Safety, and Tolerability of PF-06823859 in Patients With Dermatomyositis

May 4, 2018 By Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

IRB: IRB00144439

Purpose of Study: Recruitment is underway in Baltimore and other sites for a research study of an investigational medicine for dermatomyositis (DM). This study will assess the effectiveness and safety of a Study drug compared to placebo. The study drug is a type of drug called a biologic and is given monthly by injection into your vein.

Eligibility Criteria:

Study volunteers must meet the following criteria: To be eligible for this trial, a patient must:
  • Be 18 to 75 years of age
  • Have a diagnosis of DM
  • Have active DM-related skin disease
  • Failed to respond to at least 1 standard of care systemic treatment like corticosteroids
  • Must be willing to undergo skin biopsies
  • Willing to come in for 10 on-site visits over 8 months
Go to ClinicalTrials.gov where you will find information on the trial recruitment status, eligibility, locations, and contact details. ClinicalTrials.gov Identifier: NCT03181893

Study Status:

Recruiting

Coordinator/Contact:

Myositis Center
(410) 550-1741

Principal Investigator:

Lisa Christopher-Stine, MD, MPH
Associate Professor of Medicine

Dr. Christopher-Stine is an Associate Professor of Medicine and Neurology and the Director and Co-Founder of the Johns Hopkins Myositis Center, a multidisciplinary clinic formally established in 2007. She joined the faculty of the Division of Rheumatology at The Johns Hopkins University in 2003. Her clinical research focus is the longitudinal clinical outcomes, phenotyping, and autoantibody associations and predictors in the idiopathic inflammatory myopathies (“myositis”). She has authored or co-authored over 100 publications. Dr. Christopher-Stine and her colleagues discovered that some statin-related myopathies are, in fact, autoimmune in nature and are associated with a specific autoantibody, anti-HMGCR.. As a clinician scientist, she utilizes the Myositis Database developed by her and her colleagues for which she is the Principal Investigator, currently numbering well over 2500 patients recruited worldwide. She was a 2018-2019 United States Myositis Association Grant Awardee for her project “ “The gut and skin microbiota in patients with DM.” Dr. Christopher-Stine will explore the significance of the microbiome in myositis patients by identifying organisms commonly occurring in dermatomyositis patients. She also has a strong interest in patient-reported outcomes and she is the co-chair of an international effort through the OMERACT organization to develop a novel patient reported outcome measure.

Use of this Site

All information contained within the Johns Hopkins Division of Rheumatology website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

RheumTV Logo

Rheum.TV is an educational platform created to help patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit RheumTV

Footer

Rheumatology Specialty Care Centers

  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect with Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2023 Johns Hopkins Rheumatology - Patient Privacy